Lisa M Marcello

Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial

J. Bussel, F. Locatelli, D. Pospíšilová, 2015, The Lancet.

Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled study.

J. Bussel, V. Blanchette, L. Krishnamurti, 2015, The Lancet. Haematology.

Safety and Efficacy of Extended Treatment with Eltrombopag in Adults with Chronic Immune Thrombocytopenia (ITP) From June 2006 to February 2011

J. Bussel, M. Saleh, G. Cheng, 2011 .

PETIT and PETIT 2: Treatment with Eltrombopag in 171 Children with Chronic Immune Thrombocytopenia (ITP)

J. Bussel, V. Blanchette, F. Locatelli, 2014 .